n.胆管癌

Cholangiocarcinoma is a rare and aggressive form of bile duct cancer.
这是一种罕见且侵袭性强的胆管癌。
The early symptoms of cholangiocarcinoma may be subtle, such as jaundice or abdominal pain.
胆管癌的早期症状可能并不明显，如黄疸或腹部疼痛。
A CT scan often reveals the presence of a tumor in the bile ducts for cholangiocarcinoma diagnosis.
通常通过CT扫描来诊断胆管癌，它会显示出胆管内的肿瘤。
Surgery is the primary treatment option for localized cholangiocarcinoma, followed by chemotherapy and radiation therapy.
对于局限性胆管癌，手术是首选治疗方法，随后可能进行化疗和放疗。
Adjuvant chemotherapy may be prescribed after surgery to reduce the risk of recurrence in cholangiocarcinoma patients.
手术后可能会给予辅助化疗，以降低胆管癌复发的风险。
The prognosis for cholangiocarcinoma varies depending on the stage at diagnosis and patient's overall health.
胆管癌的预后因诊断时的阶段和患者的整体健康状况而异。
Early detection through regular screening can improve survival rates for patients with cholangiocarcinoma.
定期筛查有助于早期发现，从而提高胆管癌患者的生存率。
Researchers are exploring targeted therapies and immunotherapies as potential new treatments for advanced cholangiocarcinoma.
研究人员正在研究靶向疗法和免疫疗法作为晚期胆管癌的潜在新治疗方案。
Supportive care, including pain management and palliative care, is crucial for patients with terminal cholangiocarcinoma.
对于晚期胆管癌患者，支持性护理，包括疼痛管理和姑息护理，至关重要。
A multidisciplinary team approach is often employed in managing cholangiocarcinoma, involving gastroenterologists, surgeons, and oncologists.
治疗胆管癌通常采用多学科团队方法，涉及胃肠科医生、外科医生和肿瘤科医生。